These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 18095019

  • 1. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
    Radeleff B, Thierjung H, Stampfl U, Stampfl S, Lopez-Benitez R, Sommer C, Berger I, Richter GM.
    Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
    [Abstract] [Full Text] [Related]

  • 2. Reduction of late in-stent stenosis in a porcine coronary artery model by cobalt chromium stents with a nanocoat of polyphosphazene (Polyzene-F).
    Stampfl U, Sommer CM, Thierjung H, Stampfl S, Lopez-Benitez R, Radeleff B, Berger I, Richter GM.
    Cardiovasc Intervent Radiol; 2008; 31(6):1184-92. PubMed ID: 18704573
    [Abstract] [Full Text] [Related]

  • 3. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S, Herdeg C.
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [Abstract] [Full Text] [Related]

  • 4. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B.
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
    Chen JL, Gao LJ, Yang YJ, Li JJ, Qiao SB, Xu B, Huang JH, Yao M, Qin XW, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Gao RL.
    Chin Med J (Engl); 2010 Apr 05; 123(7):778-81. PubMed ID: 20497663
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
    Satzl S, Henn C, Christoph P, Kurz P, Stampfl U, Stampfl S, Thomas F, Radeleff B, Berger I, Grunze M, Richter GM.
    Invest Radiol; 2007 May 05; 42(5):303-11. PubMed ID: 17414526
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents.
    Henn C, Satzl S, Christoph P, Kurz P, Radeleff B, Stampfl U, Stampfl S, Berger I, Richter GM.
    J Vasc Interv Radiol; 2008 Mar 05; 19(3):427-37. PubMed ID: 18295704
    [Abstract] [Full Text] [Related]

  • 8. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 9. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV, Fernandes MR, Madonna R, Clubb F, Oliveira E, Jimenez-Quevedo P, Branco R, Lopez J, Angeli FS, Sanz-Ruiz R, Vaughn WK, Zheng Y, Baimbridge F, Canales J, Cardoso CO, Assad JA, Falotico R, Perin EC.
    Catheter Cardiovasc Interv; 2009 May 01; 73(6):801-8. PubMed ID: 19309735
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model.
    Radeleff B, Lopez-Benitez R, Stampfl U, Stampfl S, Sommer C, Thierjung H, Berger I, Kauffmann G, Richter GM.
    J Vasc Interv Radiol; 2010 Aug 01; 21(8):1262-70. PubMed ID: 20656224
    [Abstract] [Full Text] [Related]

  • 11. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller S, Coleman L, Virmani R.
    Catheter Cardiovasc Interv; 2006 Jul 01; 68(1):97-103. PubMed ID: 16755598
    [Abstract] [Full Text] [Related]

  • 12. The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
    Huang Y, Venkatraman SS, Boey FY, Umashankar PR, Mohanty M, Arumugam S.
    J Interv Cardiol; 2009 Oct 01; 22(5):466-78. PubMed ID: 19627432
    [Abstract] [Full Text] [Related]

  • 13. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL, Yang YJ, Gao LJ, Huang JH, Qin XW, Qiao SB, Xu B, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Li JJ, Gao RL.
    Chin Med J (Engl); 2008 Nov 05; 121(21):2144-7. PubMed ID: 19080174
    [Abstract] [Full Text] [Related]

  • 14. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
    Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R.
    Circulation; 2009 Jul 14; 120(2):141-9, 1-2. PubMed ID: 19564562
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb 14; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel-induced arterial wall toxicity and inflammation: part 2--long-term tissue response in a minipig model.
    Stampfl U, Radeleff B, Sommer C, Stampfl S, Lopez-Benitez R, Thierjung H, Kurz P, Berger I, Richter GM.
    J Vasc Interv Radiol; 2009 Dec 14; 20(12):1608-16. PubMed ID: 19944986
    [Abstract] [Full Text] [Related]

  • 17. Cypher versus taxus: are there differences?
    Silber S.
    J Interv Cardiol; 2005 Dec 14; 18(6):441-6. PubMed ID: 16336424
    [Abstract] [Full Text] [Related]

  • 18. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B, Karthikeyan G, Shankar PB, Seth S, Singh S, Pr U, Lal AV, Mohanty M.
    Indian Heart J; 2008 Dec 14; 60(3):228-32. PubMed ID: 19240312
    [Abstract] [Full Text] [Related]

  • 19. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O, Lagerqvist B, Carlsson J, Lindbäck J, Stenestrand U, James SK.
    J Am Coll Cardiol; 2009 May 05; 53(18):1660-7. PubMed ID: 19406341
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of balloon withdrawal forces with bare-metal stents, compared with Taxus and Cypher drug-eluting coronary stents: balloon, stent and polymer interactions.
    Turk M, Gupta V, Fischell TA.
    J Invasive Cardiol; 2010 Mar 05; 22(3):113-6. PubMed ID: 20197577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.